Lilian Xu

Point/Counterpoint Counterpoint: The Myeloperoxidase 463 G3 A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians 1

D. Christiani, J. Wain, T. Lynch, 2002 .

Genotyping Patients With Recent Blood Transfusions

D. Christiani, M. Gong, B. Thompson, 2003, Epidemiology.

Genetic Polymorphism in p53 Codon 72 and Skin Cancer in Southwestern Taiwan

Thomas J. Smith, Y. Hsueh, D. Christiani, 2003, Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering.

G3A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians

D. Christiani, J. Wain, T. Lynch, 2002 .

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

D. Christiani, J. Wain, T. Lynch, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS.

D. Christiani, M. Gong, B. Thompson, 2004, Chest.

Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome*

D. Christiani, M. Gong, R. Zhai, 2008, Critical care medicine.

Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.

D. Christiani, J. Wain, T. Lynch, 2001, Cancer research.

Counterpoint: The Myeloperoxidase (cid:1) 463 G 3 A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians 1

D. Christiani, J. Wain, T. Lynch, 2002 .

Surfactant protein-B polymorphisms and mortality in the acute respiratory distress syndrome*

R. Zhai, L. Pothier, Lilian Xu, 2008, Critical care medicine.